Skip to content

UCL Technology Fund Showcase 2021

Calendar icon to

Proudly supported by


Amali de Alwis

CEO (incoming), Founders Forum and most recently Managing Director of Microsoft for Startups UK

Kerry Baldwin

Co-founder and Managing Partner, IQ Capital

Professor Phil Beales

Co-founder and CEO, Axovia

Dr Claire Booth

Senior Clinical Lecturer, UCL Great Ormond Street Institute of Child Health

Dr Leigh Brody

Investment Manager, UCL Technology Fund

Rael Cline

Co-founder, Nozzle

Dr Toby Cubbitt

Co-founder, Phasecraft

Professor Adrien Desjardins

Co-founder, Echopoint

Dr Mark Dickinson

CEO, Intrinsic

Dr Andrew Elder

Partner, AlbionVC and UCL Technology Fund

Dr Malcolm Finlay

Co-founder, Echopoint

Dr Jonathan Fisher

T Cell POC

Professor Paul Gissen

Professorial Research Associate, UCL

Dr Simon Goldman

Investment Director, UCL Technology Fund

David Grimm

Investment Director, UCL Technology Fund

Raza Habib

Co-founder, Humanloop

Dr Victor Hernandez

Co-Founder and CSO, Axovia

Ian Hogarth

Angel Investor and Chair, Phasecraft

Professor Tony Kenyon

Co-founder, Intrinsic

Dr Anne Lane


Dominik Leisi

Investment Manager, UCL Technology Fund

Dr Gabriele Lignani

UCL Queen Square Institute of Neurology, in the Department of Clinical and Experimental Neuroscience

Victor Malachard

Executive Chair, Nozzle

Mish Mashkautsan

Partner, LocalGlobe

Dr Tom Mason

Founder, Bramble

Dr Adnan Mehonic

Co-founder, Intrinsic

Dr Natalia Misciattelli

Chief Business Officer, NovalGen

Ashley Montanaro

Co-founder, Phasecraft

Professor John Morton

Co-founder, Phasecraft

Professor Amit Nathwani

CEO, NovalGen

Antony Odell

Executive Chair, Echopoint

Dr Tanel Ozdemir

Investment Manager, UCL Technology Fund

Professor Sir Mark Pepys


Professor David Price

UCL Vice-Provost (Research, Innovation & Global Engagement)

Marina Santilli

Associate Director (Physical Sciences & Engineering), UCLB

Dr Tim Sparey

CEO, PanAngium

The event is over

Hosted by

Albion Capital

Albion Capital Group LLP is a leading independent investment manager with a long-term record of backing change and growth. Founded in 1996, Albion manages six Venture Capital Trusts with assets of c.£550 million. The wider Albion Group has funds of c.£880 million under investment management, expected commitment or administration.


Axovia Therapeutics

Life sciences


Life sciences


Life sciences


Physical Sciences


Physical Sciences


Physical Sciences


Physical Sciences

Bramble Energy

Physical Sciences


Physical Sciences